Trials / Sponsors / DNAtrix, Inc.
DNAtrix, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Suspended | DNX-2440 for Resectable Colorectal Liver Metastasis Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer | Phase 1 | 2021-02-15 |
| Completed | Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects Brain Cancer, Brain Neoplasm, Glioma | Phase 2 | 2016-10-06 |
| Completed | DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors Glioblastoma or Gliosarcoma | Phase 1 | 2014-09-11 |
| Completed | DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas Brain Cancer, Central Nervous System Diseases | Phase 1 | 2009-02-01 |